Correlation Between Apollomics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apollomics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apollomics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apollomics Class A and Transcode Therapeutics, you can compare the effects of market volatilities on Apollomics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apollomics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apollomics and Transcode Therapeutics.
Diversification Opportunities for Apollomics and Transcode Therapeutics
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Apollomics and Transcode is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Apollomics Class A and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Apollomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apollomics Class A are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Apollomics i.e., Apollomics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Apollomics and Transcode Therapeutics
Given the investment horizon of 90 days Apollomics Class A is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Apollomics Class A is 5.51 times less risky than Transcode Therapeutics. The stock trades about -0.27 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 364.00 in Transcode Therapeutics on November 4, 2024 and sell it today you would earn a total of 392.00 from holding Transcode Therapeutics or generate 107.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.0% |
| Values | Daily Returns |
Apollomics Class A vs. Transcode Therapeutics
Performance |
| Timeline |
| Apollomics Class A |
| Transcode Therapeutics |
Apollomics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apollomics and Transcode Therapeutics
The main advantage of trading using opposite Apollomics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apollomics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Apollomics vs. Sonida Senior Living | Apollomics vs. Inhibrx | Apollomics vs. Aperture Health | Apollomics vs. Tarsus Pharmaceuticals |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |